Skip to main content

Why did the chicken cross the DNA?

Advances in transgenics and drug production are foreseen using chicken eggs, says the Roslin Institute. But why chickens?

Written byDavid Nicholson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

EDINBURGH The Roslin Institute held a special news conference today, delighting scientists with the idea of producing drugs in chicken eggs but disappointing the media when 'Britney' the hen failed to make an appearance.

The Roslin Institute reached celebrity status when it gave birth to Dolly the sheep in 1997. Its latest project is in collaboration with Viragen, Inc., a US biotech company based in Plantation, Florida and Edinburgh. "The essence of this project is to create chickens which produce eggs containing new drugs to treat many serious diseases, including cancer," said Dr Helen Sang, lead scientist on avian transgenic technology at the Roslin Institute.

Dr Sang was the first person to produce a trangenic chicken by direct injection. First generation transgenics has had a low success rate, however, because the process is very difficult to control. DNA is directly injected into the germinal disk of a hen's egg, where ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo